September/October 2016
Resource Use Among Nonvalvular Atrial Fibrillation Patients
October 19, 2016
Article
Web Exclusives
This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or Ustekinumab
October 19, 2016
Article
Original Research
This retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Medicare Part D Insulin Tiering Change: Impact on Health Outcomes
October 19, 2016
Article
Web Exclusives
This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Electronic Prescribing of Controlled Substances: A Tool to Help Promote Better Patient Care
October 18, 2016
Article
Original Research
This study presents the first information available regarding enablement and use by state and area characteristics of electronic prescribing of controlled substances by prescribers and pharmacy systems in from an e-prescribing network.
Introduction to the Hospital-Acquired Condition Reduction Program for Pharmacy
October 18, 2016
Article
Specialty Healthcare Benefits Council
This manuscript addresses pharmacist understanding of and/or involvement with the Hospital-Acquired Condition Reduction Program (HACRP) at their institutions.
The Pharmacy and Therapeutics Committee Revisited: Transparency in Focus
October 18, 2016
Article
From the Editor
The role of Pharmacy and Therapeutic committees in formulary creations raises concerns.